Q3 2010

Filed Aug 20, 2010 · 10-Q · 51 days after period end · 0001062993-10-002756

Q3 2010 · 10-Q

Revenue—

Net Income

-$1.97M

no prior Q3 2009 on file

EPS Diluted

-$0.09

no prior Q3 2009 on file

Operating Income-$1,302,864—

Same quarter

no prior Q3 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Jun 30, 2010 · filed Aug 20, 2010 · 51 d after period end

Anavex Life Sciences Corp. · CIK 1314052 · Engraved from SEC EDGAR